石墨烯旗舰石墨烯杂志：石墨烯在医疗保健和生物医学领域的应用
By: Tom Foley
石墨烯能改变医疗保健的未来吗？从基于石墨烯的可穿戴监控，以优化运动员的状态或跟踪伤口愈合到可以记录大脑活动或提供人工视网膜视觉的植入物，石墨烯和二维材料在许多下一代生物医学技术中具有巨大的潜力。
为此，石墨烯旗舰公司的几个合作伙伴，以及我们的一些行业领导的先锋项目和支项目公司，正在致力于令人兴奋的发展，这可能会给市场带来新的基于石墨烯的医疗设备。下面，我们将着重介绍下其中六项有希望的创意。
一个是Chemsens，一个开发基于石墨烯的人类皮肤石膏传感器的倡议。石墨烯能够快速检测和分析关键的生物指标，如汗水中的钠、钾、乳酸和葡萄糖水平。 石膏可以测量生物物理压力，然后将信息传递到电子设备，并可以帮助运动员充分优化他们的训练。 该传感器具有四个独立的部件，这些部件可以单独操作，并利用纸基流体技术改善汗液流入传感器，能够温和、快速地检测，同时确保操作是安全的用户。
同样在可穿戴设备日益扩大的领域，GraPheal开发了一种开创性的可穿戴贴片来远程监测慢性伤口。 柔性和透明的基于石墨烯的生物传感器连续记录和存储伤口生物特征数据，然后通过智能手机应用程序将其传递给云。 利用这一技术，医生和护士可以远程监测患者的伤口愈合情况，如果出现任何感染或医疗并发症，可以立即发出警报。 GraPheal目前还在开发一种基于唾液取样的石墨烯辅助诊断测试，以快速筛选Covid-19感染。
新的支项目公司InbrainNeuroElectronics诞生于一种开拓精神。来自西班牙icn2和icrea的脑科学家正在研究基于石墨烯的植入物，以记录大脑活动，用于治疗帕金森病和癫痫等脑疾病。智能设备是建立在一个创新的石墨烯电极周围，以解码高保真的神经信号，使个性化的治疗反应。该支项目已经吸引了四家投资公司在2020年早些时候的€100万投资，以加快其发展。
HEALTHCARE AND BIOMEDICINE ENHANCED BY GRAPHENE
By: Tom Foley
Could graphene transform the future of healthcare? From graphene-based wearable monitors to optimise athletes’ performance or track wound healing to implants that can record brain activity or provide artificial retinal vision, graphene and layered materials have great potential for a number of next-generation biomedical technologies.
To this end, several partners of the Graphene Flagship, along with some of our industry-led Spearhead Projects and spin-off companies, are working on exciting developments that could bring new graphene-based medical devices to the market. Here, we highlight six of these promising initiatives.
One is CHEMsens, an initiative to develop a graphene-based plaster sensor for human skin. Graphene enables the quick detection and analysis of key biological constants, like the levels of sodium, potassium, lactic acid and glucose in the sweat. The plaster can measures biophysical stress and transfer information to electronic devices, and could help athletes to fully optimise their training. The sensor features four independent devices that can operate separately, and utilises paper-based fluidics to improve sweat flow into the sensor, enabling smooth and swift detection – while ensuring operation is safe for the user.
Also in the ever-expanding realm of wearables, Grapheal have developed a pioneering wearable patch to remotely monitor chronic wounds. The flexible and transparent graphene-based biosensor continuously records and stores biometric wound data, which is then communicated to the cloud thanks to a smartphone app. Using this technology, doctors and nurses can remotely monitor wound healing in their patients, with prompt alerts if any infections or medical complications arise. Grapheal are also currently developing a graphene-enabled diagnostic test based on saliva sampling to rapidly screen for the COVID-19 infection.
New spin-off company INBRAIN Neuroelectronics was born with a pioneering spirit in mind. Originating from ICN2 and ICREA, Spain, INBRAIN scientists are working on graphene-based implants to record brain activity for the treatment of brain disorders like Parkinson’s and epilepsy. The smart devices are built around an innovative graphene electrode to decode neural signals with high fidelity, enabling a personalised therapeutic response. The spin-off already attracted a €1 million invest-ment from four investment firms earlier in 2020 to accelerate their development.